Article: Cracks Are Forming in Cronos Group Stock

Article - Media, Publications

Cracks Are Forming in Cronos Group Stock

Todd Shriber, 28 March 2019

As has been widely noted since the start of the year, marijuana equities are among 2019’s best-performing issues. Until recently, it would have been accurate to include Cronos Group (NASDAQ:CRON) in that conversation. Although the ides of March recently struck Cronos Group stock, shares of the Canadian cannabis company are still up 94.80% this year (as of March 27). In fact, Wednesday could go down as a day of infamy for Cronos Group stock.

In late trading, CRON stock was down more than 11% on above-average volume after Canaccord Genuity analysts Matt Bottomley and Bobby Burleson downgraded the shares to “sell” from “hold.” Late Wednesday, Cronos Group stock was clinging to the $18 area, well above Canaccord’s price target of $12.68. “While the sales of Canada’s other prominent producers ranged from $15 million to $60 million in the December quarter — the first in which the country allowed recreational sales to adults — Cronos managed just $4 million in sales of both medical and recreational pot,” reports Barron’s. “That even missed the low-bar of Canaccord’s forecast for $5 million.”
Continue reading “Article: Cracks Are Forming in Cronos Group Stock”

Article: Rewalk Robotics Ltd (RWLK)

Article - Media, Publications

Rewalk Robotics Ltd (RWLK)

SEC, 20 September 2017

We are offering ordinary shares, par value NIS 0.01 per ordinary share. The offering price is $ per ordinary share. Our ordinary shares are listed on the NASDAQ Capital Market under the symbol “RWLK.” The last reported sales price of our ordinary shares on September 19, 2017 was $1.70 per ordinary share.

We are an “emerging growth company” as defined under the federal securities laws and, as such, may continue to elect to comply with certain reduced public company reporting requirements in future reports.

Investing in our ordinary shares involves a high degree of risk. See “Risk Factors” beginning on page 6 of this prospectus as well as the risk factors and other information in any documents we incorporate by reference into this prospectus. See “Where You Can Find More Information” and “Incorporation of Certain Documents by Reference.”

Read Full Article

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?